Beersheba, Israel

Alexander Konson

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Clevexel Pharma. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Konson. Retrieved from https://idiyas.com/inventor/alexander-konson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexander Konson: Innovator in Kinase Modulation

Introduction

Alexander Konson is a notable inventor based in Beersheba, Israel. He has made significant contributions to the field of biotechnology, particularly in the area of kinase signaling. His work focuses on developing innovative methods and compositions that can modulate kinase activity, which is crucial for various biological processes.

Latest Patents

Konson holds a patent for "Compositions and methods for modulating a kinase." This invention relates to compounds and methods designed to influence one or more components of a kinase signaling cascade. His research has the potential to impact therapeutic approaches in treating diseases linked to kinase dysfunction.

Career Highlights

Konson is currently associated with Clevexel Pharma, where he continues to advance his research in kinase modulation. His expertise and innovative mindset have positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

He collaborates with talented professionals such as Oren Becker and Itai Bloch, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Alexander Konson's work in kinase modulation exemplifies the impact of innovative research in biotechnology. His contributions are paving the way for new therapeutic strategies and enhancing our understanding of cellular signaling pathways.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…